Beijing Health (Holdings) Past Earnings Performance
Past criteria checks 0/6
Beijing Health (Holdings) has been growing earnings at an average annual rate of 17.2%, while the Healthcare industry saw earnings growing at 5.1% annually. Revenues have been declining at an average rate of 2.3% per year.
Key information
17.2%
Earnings growth rate
17.1%
EPS growth rate
| Healthcare Industry Growth | 11.3% |
| Revenue growth rate | -2.3% |
| Return on equity | -3.2% |
| Net Margin | -44.1% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Beijing Health (Holdings) (HKG:2389) Is In A Good Position To Deliver On Growth Plans
Mar 01
Companies Like Beijing Health (Holdings) (HKG:2389) Are In A Position To Invest In Growth
Sep 12A Look At The Fair Value Of Beijing Health (Holdings) Limited (HKG:2389)
Feb 07Health Check: How Prudently Does Beijing Health (Holdings) (HKG:2389) Use Debt?
Oct 18Is Beijing Health (Holdings) (HKG:2389) Using Debt In A Risky Way?
May 31Is Beijing Enterprises Medical and Health Industry Group (HKG:2389) Using Too Much Debt?
Dec 15Revenue & Expenses BreakdownBeta
How Beijing Health (Holdings) makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 140 | -62 | 104 | 0 |
| 30 Sep 23 | 147 | -71 | 103 | 0 |
| 30 Jun 23 | 153 | -81 | 101 | 0 |
| 31 Mar 23 | 160 | -89 | 108 | 0 |
| 31 Dec 22 | 166 | -98 | 116 | 0 |
| 30 Sep 22 | 191 | -79 | 115 | 0 |
| 30 Jun 22 | 216 | -60 | 114 | 0 |
| 31 Mar 22 | 210 | -50 | 114 | 0 |
| 31 Dec 21 | 204 | -39 | 115 | 0 |
| 30 Sep 21 | 184 | -81 | 121 | 0 |
| 30 Jun 21 | 164 | -122 | 127 | 0 |
| 31 Mar 21 | 157 | -154 | 129 | 0 |
| 31 Dec 20 | 150 | -185 | 132 | 0 |
| 30 Sep 20 | 173 | -311 | 146 | 0 |
| 30 Jun 20 | 196 | -438 | 161 | 0 |
| 31 Mar 20 | 198 | -430 | 167 | 0 |
| 31 Dec 19 | 201 | -422 | 173 | 0 |
| 30 Sep 19 | 183 | -215 | 189 | 0 |
| 30 Jun 19 | 165 | -8 | 204 | 0 |
| 31 Mar 19 | 172 | 18 | 220 | 0 |
| 31 Dec 18 | 179 | 43 | 235 | 0 |
| 30 Sep 18 | 172 | 152 | 241 | 0 |
| 30 Jun 18 | 164 | 261 | 246 | 0 |
| 31 Mar 18 | 147 | 237 | 234 | 0 |
| 31 Dec 17 | 131 | 214 | 221 | 0 |
| 30 Sep 17 | 151 | 48 | 209 | 0 |
| 30 Jun 17 | 170 | -118 | 196 | 0 |
| 31 Mar 17 | 167 | -93 | 200 | 0 |
| 31 Dec 16 | 164 | -68 | 203 | 0 |
| 30 Sep 16 | 104 | -87 | 209 | 0 |
| 30 Jun 16 | 43 | -107 | 215 | 0 |
| 31 Mar 16 | 22 | -105 | 182 | 0 |
| 31 Dec 15 | 0 | -103 | 148 | 0 |
| 30 Sep 15 | 0 | -60 | 92 | 0 |
| 30 Jun 15 | 0 | -16 | 37 | 0 |
| 31 Mar 15 | 0 | -16 | 25 | 0 |
| 31 Dec 14 | 0 | -16 | 13 | 0 |
| 30 Jun 14 | -21 | 12 | 11 | 0 |
| 31 Mar 14 | 119 | 27 | 21 | 0 |
| 31 Dec 13 | 259 | 42 | 31 | 0 |
| 30 Sep 13 | 732 | 126 | 49 | 0 |
| 30 Jun 13 | 1,021 | 157 | 47 | 0 |
Quality Earnings: 2389 is currently unprofitable.
Growing Profit Margin: 2389 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2389 is unprofitable, but has reduced losses over the past 5 years at a rate of 17.2% per year.
Accelerating Growth: Unable to compare 2389's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2389 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (13.4%).
Return on Equity
High ROE: 2389 has a negative Return on Equity (-3.16%), as it is currently unprofitable.